<DOC>
	<DOCNO>NCT02782559</DOCNO>
	<brief_summary>Randomized controlled trial ass efficacy Sildenafil addition expectant management treatment preterm preeclampsia</brief_summary>
	<brief_title>Efficacy Sildenafil Preterm Preeclampsia</brief_title>
	<detailed_description>Preeclampsia major cause maternal mortality . When preeclampsia present prior thirty-four week gestation , expectant management standard practice stable patient goal extend pregnancy therefore decrease risk adverse outcome premature neonate . Our aim ass efficacy Sildenafil , phosphodiesterase inhibitor , versus placebo , addition expectant management , treatment preterm preeclampsia prolong pregnancy .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Hospitalized patient gestational age ≥24 0/7 week ≤32 0/7 week . 2 . Dating pregnancy ultrasound &lt; equal 22 week IVF conception 3 . Diagnosis Preterm Preeclampsia Superimposed Preeclampsia 1 . Need immediate delivery fetus 2 . Known lethal anomaly 3 . Preexisting renal disease 4 . Hypersensitivity sildenafil 5 . Pregestational diabetes , class C ( onset prior 1019 duration 1019 yr 6 . Active peptic ulcer disease 7 . Undergoing nitrate therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>